Ergoteles’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ergoteles’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-494,562	Closed	-$7.39M	–	2020
2022 Q4	$7.39M	Buy	+494,562	New	+$6.85M	0.27%	89
2021 Q3	–	Sell	-97,800	Closed	-$645K	–	1889
2021 Q2	$645K	Buy	+97,800	New	+$674K	0.01%	684

Ergoteles's AVEO Position: Q1 2023 in Review

Ergoteles sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 494,562 shares — an estimated $7.39M sold.

Ergoteles first reported a position in AVEO in Q2 2021 and held it in 2 quarters. The position peaked at $7.39M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Ergoteles reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 494,562 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $7.39M.
Ergoteles first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
Ergoteles's AVEO Pharmaceuticals, Inc. position peaked at $7.39M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.